Reduced body weight, visceral and liver fat accumulation as well as development of hyperinsulinemia and hyperleptinemia. Furthermore, treatment with catechins significantly increased acyl-CoA oxidase and medium chain acyl-CoA dehydrogenase mRNA expression and β-oxidation activity in the liver of mice. The gene discussed is ACADM; the disease is Hyperinsulinemia.